WMT

126.59

+1.13%↑

COST

1,008.34

+0.55%↑

150.54

+0.07%↑

77.34

-0.44%↓

174.3

+1.34%↑

WMT

126.59

+1.13%↑

COST

1,008.34

+0.55%↑

150.54

+0.07%↑

77.34

-0.44%↓

174.3

+1.34%↑

WMT

126.59

+1.13%↑

COST

1,008.34

+0.55%↑

150.54

+0.07%↑

77.34

-0.44%↓

174.3

+1.34%↑

WMT

126.59

+1.13%↑

COST

1,008.34

+0.55%↑

150.54

+0.07%↑

77.34

-0.44%↓

174.3

+1.34%↑

WMT

126.59

+1.13%↑

COST

1,008.34

+0.55%↑

150.54

+0.07%↑

77.34

-0.44%↓

174.3

+1.34%↑

Strona główna・Stock List・Lifecore Biomedical Inc

Lifecore Biomedical Inc

Closed

SectorConsumer defensive

6.52 -0.76

Buy Sell

Overview

Share price change

24h

Current

Min

6.39

Max

6.54

Key metrics
By Trading Economics
Income	-7.9M -10M
Sales	-5.3M 31M
Profit margin	-32.116
Employees	406

Dividends
By Dow Jones
Next Earnings	16 mar 2026

Market Stats
By TradingEconomics
Market Cap	-12M 229M
Previous open	7.28
Previous close	6.52

News Sentiment

By Acuity

50%

52 / 131 Ranking in Consumer defensive

Lifecore Biomedical Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

13 mar 2026, 19:08 UTC

Major News Events

TotalEnergies Shutting Production in Qatar, Iraq Amid Fighting in Middle East

13 mar 2026, 18:48 UTC

Earnings

Major Market Movers

Capricor Therapeutics Falls on Wider-Than-Expected 4Q Loss

13 mar 2026, 17:10 UTC

Major News Events

Week Ahead for FX, Bonds: Central Bank Decisions in Focus After Jump in Energy Prices

13 mar 2026, 17:10 UTC

Major News Events

Week Ahead for FX, Bonds: Central Bank Decisions -2-

13 mar 2026, 16:47 UTC

Major News Events

The Week in Oil: Hormuz Crisis Pushes Brent Above $100

13 mar 2026, 22:27 UTC

Market Talk

Major News Events

Bahrain Faces Uncertainty But Has Support Amid War, S&P Says -- Market Talk

13 mar 2026, 22:13 UTC

Market Talk

Major News Events

Saudi Arabia Seen as Able to Weather Iran Conflict, S&P Says -- Market Talk

13 mar 2026, 22:04 UTC

Market Talk

Major News Events

Emirate of RAK Outlook Stable Despite Iran War, S&P Says -- Market Talk

13 mar 2026, 22:00 UTC

Acquisitions, Mergers, Takeovers

Trump Administration Set to Receive $10 Billion Fee for Brokering TikTok Deal -- WSJ

13 mar 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

13 mar 2026, 20:50 UTC

Market Talk

Major News Events

Financial Services Roundup: Market Talk

13 mar 2026, 20:02 UTC

Market Talk

Canada Rate Hike in 2026 Would Mark 'Extraordinarily Bad' Policy -- Market Talk

13 mar 2026, 19:50 UTC

Market Talk

Major News Events

Oil Posts Weekly Gains As Middle East Conflict Drags On -- Market Talk

13 mar 2026, 19:35 UTC

Major News Events

Oil Prices Hover Near $100. India Asks Iran to Allow 23 Tankers Through Strait of Hormuz. -- Barrons.com

13 mar 2026, 19:00 UTC

Market Talk

U.S. Natural Gas Futures Settle Lower -- Market Talk

13 mar 2026, 18:49 UTC

Major News Events

The Iran War Could Upend AI. Here's How. -- Barrons.com

13 mar 2026, 18:24 UTC

Major News Events

Impact of Middle East Conflict on TotalEnergies Activities

13 mar 2026, 18:00 UTC

Major News Events

Is War Good For the Economy? -- WSJ

13 mar 2026, 17:23 UTC

Market Talk

U.S. Oil Rig Count Rises by 1 to 412 -- Market Talk

13 mar 2026, 16:46 UTC

Market Talk

Major News Events

European Indexes End Week Lower as Oil Takes Driving Seat -- Market Talk

13 mar 2026, 16:38 UTC

Major News Events

Higher Oil Prices Could Bring a Global Economic Shock. This Is the Number to Watch. -- Barrons.com

13 mar 2026, 16:34 UTC

Acquisitions, Mergers, Takeovers

EQT Says It Received Around CHF21 Bln in Total From Galderma Share Sales

13 mar 2026, 16:33 UTC

Acquisitions, Mergers, Takeovers

EQT Receives Proceeds of Around CHF1.3B From Sell-Down

13 mar 2026, 16:32 UTC

Acquisitions, Mergers, Takeovers

EQT Completes Exit From Galderma

13 mar 2026, 16:20 UTC

Market Talk

Major News Events

Financial Services Roundup: Market Talk

13 mar 2026, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

13 mar 2026, 16:15 UTC

Major News Events

Why Exxon and Energy Stocks Finally Started to Rise This Week as the Iran War Escalated -- Barrons.com

13 mar 2026, 16:11 UTC

Market Talk

Carney Tries to Put Dismal Canada Jobs Data in Context -- Market Talk

13 mar 2026, 16:00 UTC

Major News Events

Here's Where the U.S. Economy Is Most Vulnerable to Iran War -- WSJ

13 mar 2026, 15:48 UTC

Market Talk

Major News Events

Oil Futures Turn Higher as Supply Worries Remain -- Market Talk

Peer Comparison

Price change

Lifecore Biomedical Inc Forecast

Rating Consensus

By TipRanks

Buy

3 ratings

Buy

Hold

Sell

Based on 3 analysts giving stock ratings to Lifecore Biomedical Inc - Dist in the past 3 months.

Sentiment

By Acuity

52 / 131 Ranking in Consumer defensive

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Lifecore Biomedical Inc

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.